Immunological And Clinical Status 14 Months After Cessation Of Natalizumab Therapy
Olaf Stuve,Petra D. Cravens, Katherine Treadaway,Theodore J. Phillips,Gina M. Remington,Gloria Von Geldern,Sabine Cepok,Mahendra P. Singh, Jan W. Cohen Tervaert,Marc De Baets,David G. Macmanus,David H. Miller, Ernst-Wilhelm Radue,Elizabeth Cameron,Nancy Monson,Richard Kim,Bernhard Hemmer,Michael K. Racke MULTIPLE SCLEROSIS（2008）
AI 理解论文
溯源树
样例
